Recombinant CEACAM5 (Arcitumomab Biosimilar) antibody

Catalog No. ABIN5668278

The Human Monoclonal anti-CEACAM5 (Arcitumomab Biosimilar) antibody is suitable to detect CEACAM5 (Arcitumomab Biosimilar) in samples from Human. It has been validated for BI, FACS and IHC (p).

Quick Overview for Recombinant CEACAM5 (Arcitumomab Biosimilar) antibody (ABIN5668278)

Target: CEACAM5 (Arcitumomab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CEACAM5 (Arcitumomab Biosimilar) antibody is un-conjugated

Application: BioImaging (BI), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Product Details anti-CEACAM5 (Arcitumomab Biosimilar) Antibody

Purpose: Anti-carcinoembryonic antigen (CEA) [Arcitumomab], Human IgG1, kappa

Specificity: Recognises human carcinoembryonic antigen.

Characteristics:

Original Species of Ab: Mouse

Original Format of Ab: Fab'

Purification: Protein A affinity purified

Purity: > 98 % as determined by SDS-PAGE

Endotoxin Level: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogen: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion normally produced in gastrointestinal tissue during fetal development, but only at very low levels in adults.

Isotype: IgG1 kappa

Application Details

Application Notes: This antibody binds to carcinoembryonic antigen and was used in the diagnosis of mammary carcinomas.

Comment:

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Restrictions: For Research Use only

Handling

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Target Details for CEACAM5 (Arcitumomab Biosimilar)

Target: CEACAM5 (Arcitumomab Biosimilar)

Background: CEA

UniProt: Q13984